Uh oh! "Danger, danger, Will Robinson!!!"
It matters naught what yhour caxx status is, REINFECTION causes much higher elevated risk of death and hospitalization.
A VA study of 5 million reveals that ALL cohorts are at risk.
If the infection has reviously penetrated mucosal protection then you are "primed" for auto immune disease.
The only place safe? Africa - fewer infections and no mass vaccination.
Watch the embedded video here: https://www.youtube.com/watch?v=_glZcWy_BA0&t=1s
Dr Philip MacMillan (h/y Ranger71) -
This information is relevant to everyone, whether vaccinated or not. The risk of covid reinfection is similar across all population groups and needs to be urgently addressed.
The risks were most pronounced in the acute phase but persisted in the postacute phase at 6 months. Compared to noninfected controls, cumulative risks and burdens of repeat infection increased according to the number of infections. Limitations included a cohort of mostly white males. The evidence shows that reinfection further increases risks of death, hospitalization and sequelae in multiple organ systems in the acute and postacute phase. Reducing overall burden of death and disease due to SARS-CoV-2 will require strategies for reinfection prevention. Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398–2405 (2022). https://doi.org/10.1038/s41591-022-02051-3
Risk and 6-month excess burden of all-cause mortality, hospitalization, at least one sequela and sequelae by organ system are plotted. Incident outcomes were assessed from reinfection to the end of the follow-up. Results from SARS-CoV-2 reinfection (n = 40,947) and no SARS-CoV-2 reinfection (n = 443,588) are compared. Adjusted HRs (dots) and 95% CIs (error bars) are presented, as are the estimated excess burden (bars) and 95% CIs (error bars). Burdens are presented per 1,000 persons at 6 months of follow-up from the time of reinfection.
Risk and 6-month excess burden of sequelae by organ system of SARS-CoV-2 reinfection versus no reinfection in 30-d intervals covering the acute and postacute phases of reinfection. Incident outcomes were assessed from reinfection to the end of the follow-up. Results from SARS-CoV-2 reinfection (n = 40,947) versus first SARS-CoV-2 infection (n = 443,588) by time since reinfection are compared. Adjusted HRs (dots) and 95% CIs (error bars) are presented for each 30-d period since the time of reinfection, as are the estimated excess burden (bars) and 95% CIs (error bars). Burdens are presented per 1,000 persons at every 30-d period of the follow-up from the time of reinfection.
Only autoimmunity could create this broad organ damage over such a long period of time. Happy to hear a better explanation.
Please support my research efforts by subscribing to Vejon Health Substack. Your support allows me to continue bringing you my insights in a timely and effective way.